J. Exp. Med., Volume 188, Number 10, November 16, 1998 1785-1793

HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

By Gillian C. Harcourt,^* Sarah Garrard,^* Miles P. Davenport,^* Anne Edwards, and Rodney E. Phillips^*

From the ^* Molecular Immunology Group, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, United Kingdom; and the  Department of Genito-Urinary Medicine, Radcliffe Infirmary, Oxford OX2 6HW, United Kingdom

Effective long-term antiviral immunity requires specific cytotoxic T lymphocytes and CD4⁺ T lymphocyte help. Failure of these helper responses can be a principle cause of viral persistence. We sought evidence that variation in HIV-1 CD4⁺ T helper epitopes might contribute to this phenomenon. To determine this, we assayed fresh peripheral blood mononuclear cells from 43 asymptomatic HIV-1⁺ patients for proliferative responses to HIV-1 antigens. 12 (28%) showed a positive response, and we went on to map dominant epitopes in two individuals, to p24 Gag restricted by human histocompatibility leukocyte antigen (HLA)-DR1 and to p17 Gag restricted by HLA-DRB52c. Nine naturally occurring variants of the p24 Gag epitope were found in the proviral DNA of the individual in whom this response was detected. All variants bound to HLA-DR1, but three of these peptides failed to stimulate a CD4⁺ T lymphocyte line which recognized the index sequence. Antigenic variation was also detected in the p17 Gag epitope; a dominant viral variant present in the patient was well recognized by a specific CD4⁺ T lymphocyte line, whereas several natural mutants were not. Importantly, variants detected at both epitopes also failed to stimulate fresh uncultured cells while index peptide stimulated successfully. These results demonstrate that variant antigens arise in HIV-1⁺ patients which fail to stimulate the T cell antigen receptor of HLA class II-restricted lymphocytes, although the peptide epitopes are capable of being presented on the cell surface. In HIV-1 infection, naturally occurring HLA class II-restricted altered peptide ligands that fail to stimulate the circulating T lymphocyte repertoire may curtail helper responses at sites where variant viruses predominate.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Goonetilleke, N., Liu, M. K.P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., Weinhold, K. J., Moore, S., CHAVI Clinical Core B, , Letvin, N., Haynes, B. F., Cohen, M. S., Hraber, P., Bhattacharya, T., Borrow, P., Perelson, A. S., Hahn, B. H., Shaw, G. M., Korber, B. T., McMichael, A. J. (2009). The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. JEM 206: 1253-1272 [Abstract] [Full Text]  
• Petravic, J., Loh, L., Kent, S. J., Davenport, M. P. (2008). CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo. J. Virol. 82: 4091-4101 [Abstract] [Full Text]  
• Ahlenstiel, G., Roomp, K., Daumer, M., Nattermann, J., Vogel, M., Rockstroh, J. K., Beerenwinkel, N., Kaiser, R., Nischalke, H.-D., Sauerbruch, T., Lengauer, T., Spengler, U., on behalf of the Kompetenznetz HIV/AIDS, (2007). Selective Pressures of HLA Genotypes and Antiviral Therapy on Human Immunodeficiency Virus Type 1 Sequence Mutation at a Population Level. CVI 14: 1266-1273 [Abstract] [Full Text]  
• Harcourt, G, Gomperts, E, Donfield, S, Klenerman, P, the Hemophilia Growth and Development Study, (2006). Diminished frequency of hepatitis C virus specific interferon {gamma} secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Gut 55: 1484-1487 [Abstract] [Full Text]  
• Scherer, A., Frater, J., Oxenius, A., Agudelo, J., Price, D. A., Gunthard, H. F., Barnardo, M., Perrin, L., Hirschel, B., Phillips, R. E., McLean, A. R., The Swiss HIV Cohort Study, (2004). From the Cover: Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc. Natl. Acad. Sci. USA 101: 12266-12270 [Abstract] [Full Text]  
• Zaunders, J. J., Dyer, W. B., Wang, B., Munier, M. L., Miranda-Saksena, M., Newton, R., Moore, J., Mackay, C. R., Cooper, D. A., Saksena, N. K., Kelleher, A. D. (2004). Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 103: 2238-2247 [Abstract] [Full Text]  
• Iyasere, C., Tilton, J. C., Johnson, A. J., Younes, S., Yassine-Diab, B., Sekaly, R.-P., Kwok, W. W., Migueles, S. A., Laborico, A. C., Shupert, W. L., Hallahan, C. W., Davey, R. T. Jr., Dybul, M., Vogel, S., Metcalf, J., Connors, M. (2003). Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2. J. Virol. 77: 10900-10909 [Abstract] [Full Text]  
• Zhan, X., Slobod, K. S., Surman, S., Brown, S. A., Lockey, T. D., Coleclough, C., Doherty, P. C., Hurwitz, J. L. (2003). Limited Breadth of a T-Helper Cell Response to a Human Immunodeficiency Virus Envelope Protein. J. Virol. 77: 4231-4236 [Abstract] [Full Text]  
• Boritz, E., Palmer, B. E., Livingston, B., Sette, A., Wilson, C. C. (2003). Diverse Repertoire of HIV-1 p24-Specific, IFN-{gamma}-Producing CD4+ T Cell Clones Following Immune Reconstitution on Highly Active Antiretroviral Therapy. J. Immunol. 170: 1106-1116 [Abstract] [Full Text]  
• Sarkar, S., Kalia, V., Murphey-Corb, M., Montelaro, R. C. (2002). Detailed Analysis of CD4+ Th Responses to Envelope and Gag Proteins of Simian Immunodeficiency Virus Reveals an Exclusion of Broadly Reactive Th Epitopes from the Glycosylated Regions of Envelope. J. Immunol. 168: 4001-4011 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS